A pooled analysis of two phase 3 ENHANCE trials evaluated whether the inhaled dual phosphodiesterase 3 and 4 inhibitor antifeminine reduces chronic obstructive pulmonary disease exacerbation frequency and...
A new national analysis provides clinicians with evidence on how chronic obstructive pulmonary disease affects post-discharge outcomes in adults with sickle cell disease hospitalized for acute chest...
A nationwide Belgian cohort study found that biologic therapy targeting interleukin (IL) 5 reduced moderate and severe exacerbations among adults with severe eosinophilic asthma, including those with...
Researchers in Graz, Austria, used machine learning and multiomics immune profiling to uncover a distinct chronic obstructive pulmonary disease subtype tied to emphysema severity and reduced gas exchange....
In a nationwide Danish trial of more than 130,000 adults aged 60 years and older, a single dose of the bivalent RSV prefusion F protein vaccine reduced all-cause cardiorespiratory hospitalizations by nearly...
A randomized clinical trial tested whether a digital health program delivered directly to patients could increase lung cancer screening rates among eligible adults. Conducted at two academic health systems,...
Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, but it’s also highly manageable with early recognition, evidence-based treatment, and coordinated care. This guide...
In a large, randomized trial, high-flow nasal oxygen was found noninferior to noninvasive ventilation for most patient groups with acute respiratory failure, though uncertainties remain for...
A randomized trial in moderate chronic obstructive pulmonary disease demonstrated that chest mobility exercises led to greater improvements in lung function and functional capacity compared with...
Patients with chronic obstructive pulmonary disease who recovered from COVID-19 had nearly double the risk of long-term mortality compared with matched controls, with the highest risk observed in severe...
